A review of genetic differences between limited and extensively passaged human cytomegalovirus strains

Reviews in Medical Virology

Volumn 11, Issue 3, 2001, Pages 191-200

  Prichard, M N ^a   Penfold, M E T ^b   Duke, G M ^a   Spaete, R R ^a   Kemble, G W ^a,b  

^a MEDIMMUNE   (United States)

^b ChemoCentryx Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT;

ANTIGENICITY; CYTOMEGALOVIRUS; FIBROBLAST; GENOME; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; REVIEW; SEQUENCE ANALYSIS; STEM CELL; STRAIN DIFFERENCE; UNITED STATES; VIRUS ISOLATION; VIRUS REPLICATION;

AMINO ACID SEQUENCE; CELLS, CULTURED; CHEMOKINES, CXC; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FIBROBLASTS; GENOME, VIRAL; HUMANS; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; SEQUENCE ALIGNMENT; VARIATION (GENETICS); VIRAL PROTEINS; VIRUS CULTIVATION; VIRUS REPLICATION;

EID: 0034991427     PISSN: 10529276     EISSN: None     Source Type: Journal    
DOI: 10.1002/rmv.315     Document Type: Review

References (71)

1. Pathogenesis of human cytomegalovirus-associated diseases. Historical perspective
2. Viral genetics
3. DNA nucleotide sequence heterogeneity between the Towne and AD169 strains of cytomegalovirus
4. Detection of human cytomegalovirus and analysis of strain variation
5. Structural organization of the DNA molecules from human cytomegalovirus
6. Structural organization of human herpesvirus DNA molecules
7. Comparison of the physical maps of the DNAs of two cytomegalovirus strains
8. Human cytomegalovirus DNA: Physical maps for restriction endonucleases BgIII, HindIII and XbaI
9. Cytomegalovirus vaccine virus (Towne strain) does not induce latency
10. Comparison of restriction site polymorphisms among clinical isolates and laboratory strains of human cytomegalovirus
11. Young children as a probable source of maternal and congenital cytomegalovirus infection
12. Cytomegalovirus transmission in a Midwest day care center: Possible relationship to child care practices
13. Differentiation of cytomegalovirus strains by restriction analysis of DNA sequences amplified from clinical specimens
14. Identification of multiple strains of cytomegalovirus in homosexual men
15. Development of a vaccine against mental retardation caused by cytomegalovirus infection in utero
16. Cytopathogenic agent resembling human salivary gland virus recovered from tissue cultures of human adenoids
17. Candidate cytomegalovirus strain for human vaccination
18. Cytomegalovirus: Genetic variation of viral genomes
19. Vaccination of pediatric nurses with live attenuated cytomegalovirus
20. Clinical trials of immunization with the Towne 125 strain of human cytomegalovirus
21. Immunisation trials with live attenuated cytomegalovirus Towne 125
22. Laboratory evaluations of infections in immunosuppressed transplant patients
23. Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues
24. Virological diagnosis of cytomegalovirus infection
25. Cytomegalovirus and its replication
26. Preservation of natural endothelial cytopathogenicity of cytomegalovirus by propagation in endothelial cells
27. Human cytomegalovirus in a SCID-hu mouse: Thymic epithelial cells are prominent targets of viral replication
28. Dramatic interstrain differences in the replication of human cytomegalovirus in SCID-hu mice
29. Quantification of replication of clinical cytomegalovirus isolates in cultured endothelial cells and fibroblasts by a focus expansion assay
30. Modification of human cytomegalovirus tropism through propagation in vitro is associated with changes in the viral genome
31. Cytomegalovirus-infected endothelial cells recruit neutrophils by the secretion of C-X-C chemokines and transmit virus by direct neutrophil-endothelial cell contact and during neutrophil transendothelial migration
32. Nuclear import as a barrier to infection of human umbilical vein endothelial cells by human cytomegalovirus strain AD169
33. In vitro generation of human cytomegalovirus pp65 antigenemia, viremia, and leukoDNAemia
34. Human cytomegalovirus replicates abortively in polymorphonuclear leukocytes after transfer from infected endothelial cells via transient microfusion events
35. Tropism of human cytomegalovirus for endothelial cells is determined by a post-entry step dependent on efficient translocation to the nucleus
36. A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism
37. Comparative virulence and immunogenicity of the Towne strain and a nonattenuated strain of cytomegalovirus
38. Protective effects of Towne cytomegalovirus vaccine against low-passage cytomegalovirus administered as a challenge
39. Cytomegalovirus vaccine trial in 400 renal transplant candidates
40. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains
41. Mechanism and application of genetic recombination in herpesviruses
42. Cytomegalovirus encodes a potent alpha chemokine
43. Chemokine receptors: Gateways to inflammation and infection
44. Human chemokines: An update
45. Chemokines and myeloid cell recruitment
46. Virus-encoded receptors for cytokines and chemokines
47. Cytomegalovirus-encoded beta chemokine promotes monocyte-associated viremia in the host
48. Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor
49. Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor
50. Functional analysis of the human cytomegalovirus US28 gene by insertion mutagenesis with the green fluorescent protein gene
51. Structure-activity relationships of interleukin-8 determined using chemically synthesized analogs. Critical role of NH2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding activities
52. Intragenic variability of human cytomegalovirus glycoprotein B in clinical strains
53. Human cytomegalovirus UL144 open reading frame: Sequence hypervariability in low-passage clinical isolates
54. The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells
55. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator
56. Cutting edge: A novel viral TNF receptor super-family member in virulent strains of human cytomegalovirus
57. Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: Implications for TNF receptor activation
58. Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes
59. Defined large-scale alterations of the human cytomegalovirus genome constructed by cotransfection of overlapping cosmids
60. Human cytomegalovirus origin of DNA replication (oriLyt) resides within a highly complex repetitive region
61. Identification of the lytic origin of DNA replication in human cytomegalovirus by a novel approach utilizing ganciclovir-induced chain termination
62. Multicomponent origin of cytomegalovirus lyric-phase DNA replication
63. Boundaries and structure of human cytomegalovirus oriLyt, a complex origin for lytic-phase DNA replication
64. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169
65. Strain-dependent differences in the human cytomegalovirus replication origin
66. A 189-bp repeat region within the human cytomegalovirus replication origin contains a sequence dispensable but irreplaceable with other sequences
67. Identification of persistent RNA-DNA hybrid structures within the origin of replication of human cytomegalovirus
68. The published DNA sequence of human cytomegalovirus strain AD169 lacks 929 base pairs affecting genes UL42 and UL43
69. Reassessing the organization of the UL42-UL43 region of the human cytomegalovirus strain AD169 genome
70. The sequence and antiapoptotic functional domains of the human cytomegalovirus UL37 Exon 1 immediate early protein are conserved in multiple primary strains
71. Differentiation of human cytomegalovirus genotypes in immunocompromised patients on the basis of UL4 gene polymorphisms